article thumbnail

Predictive Medicine Depends on Analytics

Harvard Business Review

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge. The positions are there for the taking. But not for long.

article thumbnail

The Growing Conflict-of-Interest Problem in the U.S. Congress

Harvard Business Review

Given that there are many reasons why a bill might fail — and many people who might be able to prevent it from coming to a vote — it is hard to prove that a particular lawmaker is motivated by their investment holdings. Not only did his wife invest between $610,000 and $1.5